These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 32017846)
1. CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway. Chen Y; Shao Z; Jiang E; Zhou X; Wang L; Wang H; Luo X; Chen Q; Liu K; Shang Z J Cell Physiol; 2020 Sep; 235(9):5995-6009. PubMed ID: 32017846 [TBL] [Abstract][Full Text] [Related]
2. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway. Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247 [TBL] [Abstract][Full Text] [Related]
3. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway. Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957 [TBL] [Abstract][Full Text] [Related]
4. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway. Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093 [TBL] [Abstract][Full Text] [Related]
5. CCR7 regulates cell migration and invasion through JAK2/STAT3 in metastatic squamous cell carcinoma of the head and neck. Liu FY; Safdar J; Li ZN; Fang QG; Zhang X; Xu ZF; Sun CF Biomed Res Int; 2014; 2014():415375. PubMed ID: 25405202 [TBL] [Abstract][Full Text] [Related]
6. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis. Pang MF; Georgoudaki AM; Lambut L; Johansson J; Tabor V; Hagikura K; Jin Y; Jansson M; Alexander JS; Nelson CM; Jakobsson L; Betsholtz C; Sund M; Karlsson MC; Fuxe J Oncogene; 2016 Feb; 35(6):748-60. PubMed ID: 25961925 [TBL] [Abstract][Full Text] [Related]
7. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway. Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944 [TBL] [Abstract][Full Text] [Related]
8. ZnAs@SiO Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768 [No Abstract] [Full Text] [Related]
9. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma. Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT Cells; 2019 Dec; 8(12):. PubMed ID: 31861233 [TBL] [Abstract][Full Text] [Related]
10. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer. Zeng YT; Liu XF; Yang WT; Zheng PS Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905 [TBL] [Abstract][Full Text] [Related]
11. CCL21/CCR7 axis activating chemotaxis accompanied with epithelial-mesenchymal transition in human breast carcinoma. Li F; Zou Z; Suo N; Zhang Z; Wan F; Zhong G; Qu Y; Ntaka KS; Tian H Med Oncol; 2014 Sep; 31(9):180. PubMed ID: 25142946 [TBL] [Abstract][Full Text] [Related]
13. C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer. Wei L; Liu Y; Ma Y; Ding C; Zhang H; Lu Z; Gu Z; Zhu C Cell Cycle; 2019 Dec; 18(24):3456-3471. PubMed ID: 31731888 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression. Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182 [TBL] [Abstract][Full Text] [Related]
15. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma. Yang M; Yao P; Lang X; Li X; Zhang D Bioengineered; 2021 Dec; 12(2):12800-12811. PubMed ID: 34895038 [TBL] [Abstract][Full Text] [Related]
16. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer. Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma. Song C; Fan B; Xiao Z Biomed Pharmacother; 2018 Feb; 98():440-445. PubMed ID: 29278854 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway. Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871 [TBL] [Abstract][Full Text] [Related]
19. Isoorientin inhibits epithelial-to-mesenchymal properties and cancer stem-cell-like features in oral squamous cell carcinoma by blocking Wnt/β-catenin/STAT3 axis. Liu SC; Huang CS; Huang CM; Hsieh MS; Huang MS; Fong IH; Yeh CT; Lin CC Toxicol Appl Pharmacol; 2021 Aug; 424():115581. PubMed ID: 34019859 [TBL] [Abstract][Full Text] [Related]
20. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1. Shi M; Chen D; Yang D; Liu XY J Exp Clin Cancer Res; 2015 Dec; 34():149. PubMed ID: 26667143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]